Due: February 13, 2024 Description: To employ unique self-detoxification capability into CB protective suits. Self-detoxifying prototypes will mitigate logistics costs associated with CBRN protective suits; the suits will render the threat inactive and thereby enabling reuse Read More
Due: March 4, 2024 The purpose of this Funding Opportunity Announcement (FOA) is to advance tools and technologies specifically designed to reduce risks to energy delivery infrastructure from all hazards including cybersecurity, physical security, and Read More
Due: March 4, 2024 The purpose of the NIDA Animal Genetics Program is to identify genetic, genomic, and molecular (epi)genetic variants that underlie: 1. Phenotypes associated with addictive behaviors and/or vulnerability to distinct stages along Read More
Due: March 7, 2024 This funding opportunity announcement (FOA) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that Read More
Due: March 5, 2024 This FOA encourages applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing Read More
Due: March 15, 2024 The purpose of this Notice of Funding Opportunity (NOFO) is to support the late-stage engineering and preclinical development of innovative biological products that safely and specifically kill HIV-infected cells. Products of Read More
Due: April 12, 2024 The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals inthe following areas of interest: computational science to build tactical mixed reality systems thatprotect human users against cognitive attack. Proposed Read More
Due: March 29, 2024 ROSES is an omnibus NRA, with many individual program elements, each with its own due dates and topics. All together these cover the wide range of basic and applied supporting research Read More
Due: March 20, 2024 This Notice of Funding Opportunity (NOFO) welcomes applications for the Consortium on Modeling Autoimmune Diabetes (CMAD) that supports the development of in vitro and in vivo models of type 1 diabetes Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.